689 / 1228
Dose to skin
D
max
< 100 % or 120 % or 140 %
J.A. Vargo, V. Verma, H. Kim, R. Kalash, D.E. Heron, R. Johnson, S. Beriwal Extended (5-year) Outcomes of
Accelerated Partial Breast Irradiation Using MammoSite Balloon Brachytherapy: Patterns of Failure, Patient
Selection, and Dosimetric Correlates for Late Toxicity. Int J Radiat Oncol Biol Phys, 81 (2014)
L.W. Cuttino, J. Heffernan, R. Vera et al. Association between maximal skin dose and breast brachytherapy
outcome: A proposal for more rigorous dosimetric constraints. Int J Radiat Oncol Biol Phys, 81 (2011)
D.W. Arthur, F.A. Vicini, D.A. Todor et al. Contura multi-lumen balloon breast brachytherapy catheter:
Comparative dosimetric findings of a phase 4 trial. Int J Radiat Oncol Biol Phys, 86 (2013)
D
max
< 70 % within GEC ESTRO and European Trials
T. Major, C. Polgar, K. Lövey, G Fröhlich. Dosimetric characteristics of accelerated partial breast irradiation
with CT image--based multicatheter interstitial brachytherapy: a single institution's experience. Brachytherapy
(2011)